Notes And Other Explanatory Information [Abstract]

Carl Zeiss Meditec AG - Filing #6472612

Concept 2023-10-01 to
2024-09-30
Notes and other explanatory information [abstract]
Disclosure of accrued expenses and other liabilities [text block]
23 Abgegrenzte
Disclosure of auditors' remuneration [text block]
Honorare des Abschlussprüfers  
Disclosure of authorisation of financial statements [text block]
Der zum 30. September 2024 aufgestellte Konzernabschluss sowie der Konzernlagebericht wurden  
Disclosure of borrowings [text block]
le
Disclosure of business combinations [text block]
Zugänge Konsolidierungskreis  
Disclosure of cash and cash equivalents [text block]
l
Disclosure of cash flow statement [text block]
26 Angaben
Disclosure of changes in accounting policies [text block]
Neue und geänderte Rechnungslegungsvorschriften  
Disclosure of debt instruments [text block]
n
Disclosure of deferred income [text block]
24 Übrige
Disclosure of dividends [text block]
n  
Disclosure of earnings per share [text block]
10 Ergebnis
Disclosure of effect of changes in foreign exchange rates [text block]
8
Disclosure of employee benefits [text block]
7
Disclosure of events after reporting period [text block]
33 Ereignisse
Disclosure of fee and commission income (expense) [text block]
16 Übrige
Disclosure of financial instruments at fair value through profit or loss [text block]
e
Disclosure of going concern [text block]
d  
Disclosure of government grants [text block]
29 Zuwendungen
Disclosure of information about hyperinflationary reporting [text block]
g  
Disclosure of impairment of assets [text block]
11 Geschäfts-
Disclosure of information about employees [text block]
Die Personalzahlen (Mitarbeiter) sowie -struktur der Gruppe stellen sich wie folgt dar:  
Disclosure of information about key management personnel [text block]
30 Beziehungen
Disclosure of investments accounted for using equity method [text block]
14 At-equity
Disclosure of issued capital [text block]
19 Eigenkapital  
Disclosure of non-controlling interests [text block]
4
Disclosure of objectives, policies and processes for managing capital [text block]
he
Disclosure of other operating income (expense) [text block]
6
Disclosure of other provisions, contingent liabilities and contingent assets [text block]
21 Übrige
Disclosure of property, plant and equipment [text block]
13 Sachanlagen  
Disclosure of research and development expense [text block]
12 Übrige
Disclosure of revenue from contracts with customers [text block]
5
Disclosure of subsidiaries [text block]
3
Disclosure of tax receivables and payables [text block]
17 Übrige
Disclosure of trade and other receivables [text block]
o  

Talk to a Data Expert

Have a question? We'll get back to you promptly.